Theradaptive Awarded Manufacturing Assistance Grant by the Maryland Stem Cell Research Fund

Today, Theradaptive a biopharmaceutical firm pioneering advancements in targeted regenerative therapeutics, has been awarded the Manufacturing Assistance Program grant by the Maryland Stem Cell Research Fund (MSCRF). The grant will help Theradaptive develop their GMP Manufacturing Facility in Frederick, stimulating economic development in the state and bolstering Maryland’s reputation as a hub of biotechnological innovation.

Theradaptive seeks to significantly improve patient outcomes by producing targeted therapeutics that can be used to coat implants, devices, and injectable carriers. Their proprietary protein-engineering platform aims to provide greater efficacy, safety, and ease of use across multiple clinical indications including orthopedics, immuno-oncology and dental.

To date, the MSCRF has invested over $177 million in the pursuit of accelerated stem cell research, cures, and commercialization. Their Manufacturing Assistance Program grant will support Theradaptive in increasing the production of their OsteoAdapt regenerative therapeutic product for spine and trauma repair in preparation for first-in-human clinical trials.

Kevin Anderson, Secretary of Commerce at the Maryland Department of Commerce comments on the award: “Maryland Commerce is thrilled to support Theradaptive, an ambitious and innovative company whose new facility will help drive economic development and enhance our state’s reputation as a leading biotechnology hub. As Theradaptive approaches human trials, this new funding will create jobs and help set Maryland apart as one of the most attractive biotech investment areas in the US.”

Ruchika Nijhara, Executive Director at the Maryland Stem Cell Research Fund (MSCRF) states: “The recent award of a Manufacturing Assistance Program grant to Theradaptive represents MSCRF’s commitment to fostering the growth of Maryland cell-based therapy companies and facilitating the establishment of biomanufacturing capabilities within the state. We are excited to witness the development and expansion of their GMP OsteoAdapt Manufacturing Facility in Maryland, which will play a pivotal role in increasing the production of their orthopedic product. Through this growth, we anticipate a positive impact on patient outcomes, benefiting millions of individuals in need.”

Ed Fix, Vice President of Manufacturing at Theradaptive adds: “We are deeply honored to be awarded a Manufacturing Support Award by MSCRF. This award will enable us to establish our own cGMP manufacturing capabilities at our Frederick headquarters and allow us to tap into the rich pipeline of talent in the Maryland area. Manufacturing will be a critical piece in our journey to bring life changing therapies to patients.”

Hot this week

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”

Avery Dennison Medical Introduces Ipdated SilFoam Lite: Sustainability, MDR Certification & Performance Improvements

The newly enhanced SilFoam Lite delivers superior efficiency and reliability, bringing improved fluid handling capabilities and improved tack. These improvements make the product ideal for customers seeking quality, high-performance solutions in wound care notes Avery Dennison Medical.

Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life

Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed™ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."